Roche Holding Stock
Roche Holding AG
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- Switzerland
- CEO
- Thomas Schinecker
- Employees
- 103,249
- Market cap
- CHF261.7 B
- IPO
- 03/08/1995
Roche Holding AG is a global healthcare enterprise headquartered in Basel, Switzerland. Founded in 1896, the company is listed on the SIX. The business model focuses on two primary areas, which are pharmaceuticals and diagnostics. Within its pharmaceutical segment, the company develops and supplies treatments for a…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Roche Holding stock: price history
1D
-0.4%
1W
+4.9%
1M
+4.0%
6M
+15.8%
YTD
+14.7%
1Y
+29.0%
2Y
+29.3%
5Y
-2.9%
10Y
+63.1%
Next earnings date
Next earnings date
No date known
Volatility around earnings
~6% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Roche Holding
Analyst assessment of Roche Holding
0
STRONG BUY
4
BUY
5
HOLD
1
SELL
0
STRONG SELL
10
TOTAL · Hold
As of: 11/09/2023
Roche Holding stock metrics
P/E
24.69
P/B
9.39
EV/EBITDA
13.2
RETURN ON EQUITY
21.0%
NET MARGIN
22.6%
DEBT/EQUITY
0.97
DIVIDEND YIELD
2.6%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
27.2%
FLOAT SHARES
216,650,204
AVG. DAILY VOLUME (30D)
30,119
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about Roche Holding stock
What does Roche Holding do?
Roche Holding AG is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in Switzerland.
The CEO is Thomas Schinecker, the company employs around 103,249 people.
The IPO was on 03/08/1995; the stock trades on SIX under the ticker RO.SW.
What do analysts say about Roche Holding stock?
10 analysts rate the stock, the consensus is Hold (as of 11/09/2023).
This is an external assessment, not a statement by Market Jury.
When does Roche Holding report next?
Around past earnings, price swings were roughly 6% stronger than usual.
Does Roche Holding pay a dividend?
Yes. The last dividend was CHF 10.80 per share, ex-date 12/03/2026, paid on 16/03/2026.
The dividend yield is 2.6% (as of 30/06/2026).
Which stocks are comparable to Roche Holding?
Comparable stocks include Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Amgen, Gilead Sciences, Pfizer and Bristol-Myers Squibb Company.
How can I get Roche Holding stock analyzed?
Clicking "Analyze stock" lets five strategies assess Roche Holding against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.